These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1725687)

  • 1. Wheal and flare responses to muscle relaxants in humans.
    Levy JH; Adelson D; Walker B
    Agents Actions; 1991 Nov; 34(3-4):302-8. PubMed ID: 1725687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of human mast cells and basophils in response to muscle relaxants.
    Stellato C; de Paulis A; Cirillo R; Mastronardi P; Mazzarella B; Marone G
    Anesthesiology; 1991 Jun; 74(6):1078-86. PubMed ID: 1710428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cutaneous and in vitro histamine release by muscle relaxants.
    North FC; Kettelkamp N; Hirshman CA
    Anesthesiology; 1987 Apr; 66(4):543-6. PubMed ID: 2436511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wheal and flare responses to opioids in humans.
    Levy JH; Brister NW; Shearin A; Ziegler J; Hug CC; Adelson DM; Walker BF
    Anesthesiology; 1989 May; 70(5):756-60. PubMed ID: 2470272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation.
    Krause K; Giménez-Arnau A; Martinez-Escala E; Farré-Albadalejo M; Abajian M; Church MK; Maurer M
    Allergy; 2013 Feb; 68(2):256-8. PubMed ID: 23320562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weal and flare responses to intradermal rocuronium and cisatracurium in humans.
    Levy JH; Gottge M; Szlam F; Zaffer R; McCall C
    Br J Anaesth; 2000 Dec; 85(6):844-9. PubMed ID: 11732517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique.
    Berg CM; Heier T; Wilhelmsen V; Florvaag E
    Acta Anaesthesiol Scand; 2003 May; 47(5):576-82. PubMed ID: 12699516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histaminoid responses to atracurium, vecuronium and tubocurarine.
    Lavery GG; Clarke RS; Watkins J
    Ann Fr Anesth Reanim; 1985; 4(2):180-3. PubMed ID: 2408513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cutaneous histamine release by neuromuscular blocking agents.
    Galletly DC
    Anaesth Intensive Care; 1986 Nov; 14(4):365-9. PubMed ID: 2436505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective preoperative survey of 300 patients using prick tests with muscle relaxants].
    Maria Y; Grosdidier R; Haberer JP; Moneret-Vautrin DA
    Ann Fr Anesth Reanim; 1989; 8(4):301-5. PubMed ID: 2479306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal histamine release by 3 muscle relaxants.
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Acta Anaesthesiol Scand; 1983 Jun; 27(3):203-5. PubMed ID: 6192671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histaminoid response after intradermal and intravenous administration of atracurium, vecuronium and tubocurarine: a comparative study.
    Lavery GG; Clarke RS; Watkins J
    Eur J Anaesthesiol; 1986 Nov; 3(6):439-47. PubMed ID: 2439328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle relaxants: a clinical update.
    Buzello W; Diefenbach C; Nigrovic V
    Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The histaminic and anaphylactic risks of atracurium].
    Laxenaire MC; Moneret-Vautrin DA; Widmer S
    Ann Fr Anesth Reanim; 1985; 4(6):495-9. PubMed ID: 2418717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants.
    Futo J; Kupferberg JP; Moss J
    Biochem Pharmacol; 1990 Feb; 39(3):415-20. PubMed ID: 1968337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Newly developed muscle relaxants].
    Fukushima K
    Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
    [No Abstract]   [Full Text] [Related]  

  • 18. Intradermal histamine releasing effect caused by Org-NC 45. A comparison with pancuronium, metocurine and d-tubocurarine.
    Booij LH; Krieg N; Crul JF
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):393-4. PubMed ID: 6162354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of mast cell activation by muscle relaxants in human skin.
    Koppert W; Blunk JA; Petersen LJ; Skov P; Rentsch K; Schmelz M
    Anesthesiology; 2001 Sep; 95(3):659-67. PubMed ID: 11575539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atracurium induced vasodilatation is not mediated by histamine in the isolated femoral artery of the rabbit.
    de Jong DM; Hoogerwerf N; Scheffer GJ; de Lange JJ; Ros HH; Sipkema P
    Eur J Anaesthesiol; 1996 Jul; 13(4):333-9. PubMed ID: 8842652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.